AHA Statement on Decision by U.S. Supreme Court to Hear AHA Case on 340B Payment Cuts

Melinda Hatton
General Counsel
American Hospital Association

July 2, 2021

 
We are pleased that the U.S. Supreme Court has agreed to hear the compelling arguments in our case on payments cuts to the 340B drug pricing program that are adversely impacting care to patients. We are hopeful that the Court will reject the appellate court decision deferring to the government’s interpretation of the law that clearly imperils the important services that the 340B program helps allow eligible hospitals and health systems to provide to vulnerable communities, many of which would otherwise be unavailable.

###

Contact:        Colin Milligan, (202) 638-5491, cmilligan@aha.org

Marie Johnson, (202) 626-2351, mjohnson@aha.org